SC
TMDI

Stephens Consulting’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Stephens Consulting’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-833
Closed -$550 – 538
2022
Q4 		$550 Hold
833
– – ﹤0.01% 477
2022
Q3 		$375 Hold
833
– – ﹤0.01% 542
2022
Q2 		$423 Hold
833
– – ﹤0.01% 529
2022
Q1 		$439 Sell
833
-500
-38% -$290 ﹤0.01% 540
2021
Q4 		$833 Buy
+1,333
New +$1.5K ﹤0.01% 664

Other funds holding TMDI

EL
Essex LLC Deer Park, Illinois $566M AUM 23.17% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
WA
Waterford Advisors Orchard Park, New York $315M AUM 15.21% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
DIS
Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Stephens Consulting's TMDI Position: Q1 2023 in Review

Stephens Consulting sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 833 shares — an estimated $550 sold.

Stephens Consulting first reported a position in TMDI in Q4 2021 and held it in 5 quarters. The position peaked at $833 in Q4 2021. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Stephens Consulting reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Stephens Consulting sold 833 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $550.
  • Stephens Consulting first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2021 and held it in 5 quarters.
  • Stephens Consulting's Titan Medical Inc. Ordinary Shares position peaked at $833 in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Stephens Consulting's 13F filing for Q1 2023, filed 19 Apr 2023.